Increased expression of mucinous glycoprotein KL-6 in human pterygium
Author:
- 1 September 2006
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 90 (9) , 1208-1209
Abstract
Pterygia represent growth onto the cornea of fibrovascular tissue continuous with the conjunctiva.1 KL-6 (Krebs von den Lunge-6) is a high molecular weight mucinous glycoprotein, and the monoclonal antibody reacts with the sugar moiety of MUC-1.2,3 We have reported that measurement of serum KL-6 levels is useful for the diagnosis and management of uveitis patients with sarcoidosis.4,5 The aim of this study was to examine the expression of KL-6, and Ki-67, a proliferation marker, in normal human conjunctiva, pterygium, and pseudopterygium tissuesKeywords
This publication has 9 references indexed in Scilit:
- Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissuesWorld Journal of Gastroenterology, 2006
- KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblastsBiochemical and Biophysical Research Communications, 2005
- Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosisGraefe's Archive for Clinical and Experimental Ophthalmology, 2005
- Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygiaBritish Journal of Ophthalmology, 2005
- Increase of KL-6 in sera of uveitis patients with sarcoidosisGraefe's Archive for Clinical and Experimental Ophthalmology, 2003
- Overexpression of Insulin-like Growth Factor-Binding Protein-2 in Pterygium Body FibroblastsInvestigative Ophthalmology & Visual Science, 2003
- Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines.2000
- New Serum Indicator of Interstitial Pneumonitis ActivityChest, 1989
- Detection of Soluble Tumor-associated Antigens in Sera and Effusions Using Novel Monoclonal Antibodies, KL-3 and KL-6, against Lung AdenocarcinomaJapanese Journal of Clinical Oncology, 1988